RA Capital Nexus Fund, L.P.
Director, Artiva Biotherapeutics, Inc.; Director, Vor Biopharma Inc.
Bought, 12 months
$7.7M
Sold, 12 months
$0.0M
Companies
2
Latest trade
Jun 11, 2026
Companies
Artiva Biotherapeutics, Inc.Director +$7.7M Vor Biopharma Inc.Director −$3.4MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.

